SynthesisAnnals of hematology2022

Efficacy and safety of nelarabine in patients with relapsed or refractory T-cell acute lymphoblastic leukemia: a systematic review and meta-analysis.

Meghavi Kathpalia et al.PubMed ↗Publisher ↗

No numbers read from the abstract.